Abiopharma

New Form SCHEDULE 13D/A - ReNew Energy Global plc <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001193125-26-343627 <b>Size:</b> 1 MB

Financial Statements and Related Announcement: Half Yearly Results

(30% Negative) ARAMARK (ARMK) Reports Q3 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023367 <b>Size:</b> 734 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023366 <b>Size:</b> 690 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023365 <b>Size:</b> 672 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023364 <b>Size:</b> 438 KB

New Form 3/A - INTERFACE INC <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0002124498-26-000002 <b>Size:</b> 4 KB

New Form 3 - Maase Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001213900-26-087552 <b>Size:</b> 6 KB

DarioHealth Reports Second Quarter 2026 Financial Results

Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023363 <b>Size:</b> 910 KB

(10% Negative) VENTURE GLOBAL, INC. (VG) Reports Q3 2026 Financial Results

New SEC Form for ResMed Inc.

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001918704-26-023362 <b>Size:</b> 734 KB